Lund Melanoma Study Group
51 – 60 of 218
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2021
-
Mark
The Prognostic Impact of Intratumoral Aryl Hydrocarbon Receptor in Primary Breast Cancer Depends on the Type of Endocrine Therapy : A Population-Based Cohort Study
(
- Contribution to journal › Article
-
Mark
BRN2 is a non-canonical melanoma tumor-suppressor
(
- Contribution to journal › Article
-
Mark
Surgery of metastatic melanoma after systemic therapy–the SUMMIST trial : study protocol for a randomized controlled trial
(
- Contribution to journal › Letter
-
Mark
Breast cancer risk factors and survival by tumor subtype : pooled analyses from the Breast Cancer Association Consortium
2021) In Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 30(4). p.623-642(
- Contribution to journal › Article
-
Mark
Survival in 31 670 patients with thin melanomas : a Swedish population-based study
(
- Contribution to journal › Article
-
Mark
Difference in Sun Exposure Habits Between Individuals with High and Low Risk of Skin Cancer
(
- Contribution to journal › Article
-
Mark
Mendelian randomisation study of smoking exposure in relation to breast cancer risk
(
- Contribution to journal › Article
-
Mark
Common Susceptibility Loci for Male Breast Cancer
(
- Contribution to journal › Article
-
Mark
St Gallen 2019 guidelines understage the axilla in lobular breast cancer : a population-based study
(
- Contribution to journal › Article
-
Mark
Rapid Identification of the Tumor-Specific Reactive TIL Repertoire via Combined Detection of CD137, TNF, and IFNγ, Following Recognition of Autologous Tumor-Antigens
(
- Contribution to journal › Article